2743 related articles for article (PubMed ID: 28107561)
1. Beta-blockers for hypertension.
Wiysonge CS; Bradley HA; Volmink J; Mayosi BM; Opie LH
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002003. PubMed ID: 28107561
[TBL] [Abstract][Full Text] [Related]
2. Beta-blockers for hypertension.
Wiysonge CS; Bradley HA; Volmink J; Mayosi BM; Mbewu A; Opie LH
Cochrane Database Syst Rev; 2012 Nov; 11():CD002003. PubMed ID: 23152211
[TBL] [Abstract][Full Text] [Related]
3. Beta-blockers for hypertension.
Wiysonge CS; Bradley HA; Volmink J; Mayosi BM; Mbewu A; Opie LH
Cochrane Database Syst Rev; 2012 Aug; (8):CD002003. PubMed ID: 22895924
[TBL] [Abstract][Full Text] [Related]
4. Beta-blockers for hypertension.
Wiysonge CS; Bradley H; Mayosi BM; Maroney R; Mbewu A; Opie LH; Volmink J
Cochrane Database Syst Rev; 2007 Jan; (1):CD002003. PubMed ID: 17253471
[TBL] [Abstract][Full Text] [Related]
5. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Chen YJ; Li LJ; Tang WL; Song JY; Qiu R; Li Q; Xue H; Wright JM
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD008170. PubMed ID: 30480768
[TBL] [Abstract][Full Text] [Related]
6. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
[TBL] [Abstract][Full Text] [Related]
7. First-line diuretics versus other classes of antihypertensive drugs for hypertension.
Reinhart M; Puil L; Salzwedel DM; Wright JM
Cochrane Database Syst Rev; 2023 Jul; 7(7):CD008161. PubMed ID: 37439548
[TBL] [Abstract][Full Text] [Related]
8. Calcium channel blockers versus other classes of drugs for hypertension.
Zhu J; Chen N; Zhou M; Guo J; Zhu C; Zhou J; Ma M; He L
Cochrane Database Syst Rev; 2022 Jan; 1(1):CD003654. PubMed ID: 35000192
[TBL] [Abstract][Full Text] [Related]
9. Calcium channel blockers versus other classes of drugs for hypertension.
Zhu J; Chen N; Zhou M; Guo J; Zhu C; Zhou J; Ma M; He L
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD003654. PubMed ID: 34657281
[TBL] [Abstract][Full Text] [Related]
10. First-line drugs for hypertension.
Wright JM; Musini VM; Gill R
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD001841. PubMed ID: 29667175
[TBL] [Abstract][Full Text] [Related]
11. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.
Martin N; Manoharan K; Davies C; Lumbers RT
Cochrane Database Syst Rev; 2021 May; 5(5):CD012721. PubMed ID: 34022072
[TBL] [Abstract][Full Text] [Related]
12. First-line drugs for hypertension.
Wright JM; Musini VM
Cochrane Database Syst Rev; 2009 Jul; (3):CD001841. PubMed ID: 19588327
[TBL] [Abstract][Full Text] [Related]
13. Calcium channel blockers for people with chronic kidney disease requiring dialysis.
Mugendi GA; Mutua FM; Natale P; Esterhuizen TM; Strippoli GF
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD011064. PubMed ID: 33000470
[TBL] [Abstract][Full Text] [Related]
14. Perioperative beta-blockers for preventing surgery-related mortality and morbidity in adults undergoing non-cardiac surgery.
Blessberger H; Lewis SR; Pritchard MW; Fawcett LJ; Domanovits H; Schlager O; Wildner B; Kammler J; Steinwender C
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD013438. PubMed ID: 31556094
[TBL] [Abstract][Full Text] [Related]
15. How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic review and meta-analysis.
Bradley HA; Wiysonge CS; Volmink JA; Mayosi BM; Opie LH
J Hypertens; 2006 Nov; 24(11):2131-41. PubMed ID: 17053529
[TBL] [Abstract][Full Text] [Related]
16. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.
Psaty BM; Lumley T; Furberg CD; Schellenbaum G; Pahor M; Alderman MH; Weiss NS
JAMA; 2003 May; 289(19):2534-44. PubMed ID: 12759325
[TBL] [Abstract][Full Text] [Related]
17. Evening versus morning dosing regimen drug therapy for hypertension.
Wu C; Zhao P; Xu P; Wan C; Singh S; Varthya SB; Luo SH
Cochrane Database Syst Rev; 2024 Feb; 2(2):CD004184. PubMed ID: 38353289
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
[TBL] [Abstract][Full Text] [Related]
19. Calcium channel blockers versus other classes of drugs for hypertension.
Chen N; Zhou M; Yang M; Guo J; Zhu C; Yang J; Wang Y; Yang X; He L
Cochrane Database Syst Rev; 2010 Aug; (8):CD003654. PubMed ID: 20687074
[TBL] [Abstract][Full Text] [Related]
20. Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease.
Chung EY; Ruospo M; Natale P; Bolignano D; Navaneethan SD; Palmer SC; Strippoli GF
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD007004. PubMed ID: 33107592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
